Munshi Amit insider trades
Munshi Amit has filed 24 Form 4s with the SEC that we hold, for Zura Bio Ltd (ZURA) (Director), Inhibikase Therapeutics, Inc. (IKT) (Director), ARNA (President and CEO, Director) and Damora Therapeutics, Inc. (GLTO) (Director), among 5 companies in all. Across all of them we count 6 purchases worth $1.7M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 365,000 shares of Inhibikase Therapeutics, Inc. worth $500.1K, dated 2024-10-21. The first filing on our record is dated 2021-08-11 and the latest 2026-06-30.
Zura Bio Ltd (ZURA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-05 | P, purchase reported on Form 4 | 117,647 | $500.0K | 2023-06-05 |
| 2024-04-22 | P, purchase reported on Form 4 | 159,744 | $500.0K | 2024-04-24 |
Inhibikase Therapeutics, Inc. (IKT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-10-21 | P, purchase reported on Form 4 | 365,000 | $500.1K | 2024-10-23 |
ARNA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-10 | P, purchase reported on Form 4 | 1,000 | $52.9K | 2021-08-11 |
| 2021-08-12 | P, purchase reported on Form 4 | 1,000 | $50.4K | 2021-08-13 |
| 2021-08-16 | P, purchase reported on Form 4 | 1,000 | $48.2K | 2021-08-17 |
Damora Therapeutics, Inc. (GLTO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Arcutis Biotherapeutics, Inc. (ARQT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1612551) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms